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Background: Checklist utilization in surgery has contributed to improved patient safety and reduced numbers of
preventable complications. A living-donor kidney transplant (LDKT) preoperative checklist embedded within
electronic medical record (EMR) was developed to enhance patient safety and prevent “never” events including:
unexpected donor-recipient blood (ABO) incompatibility, positive (XM) cross match, infectious disease transmission, or
procurement of an anatomically inappropriate allograft. Review of the initial 2 years of checklist utilization was performed.
Findings: This safety instrument operates by facilitating critical review and referencing of source documentation
to confirm ABO, XM, infectious risk, and organ anatomy compatibility. It was met with high compliance rates and
no “never events” have occurred following its inception. The checklist is readily available in the EMR and is accessible
by all members of the LDKT recipient healthcare team.
Conclusions: Checklist utilization was associated with zero LDKT “never event” occurrences. Surgeons felt the checklist
was easy to use.Findings
Introduction
Living donor kidney transplantation is accepted world-
wide as the preferred form of renal replacement. Re-
cently, there has been enhanced attention to LDKT per
reports of preventable disease transmission and organ
incompatibility [1–6]. Transmissible disease in solid
organ transplantation is rare. A study by the Organ
Procurement and Transplantation Network (OPTN)
with the United Network for Organ Sharing (UNOS)
determined that in 2007 up to 5 malignancies and 12
infections were transmitted with solid organ trans-
plants [3]. The UNOS website notes 28,366 solid organ
transplants were completed that year, which translates
into a maximum 0.056 % rate of transmissible disease.
As such, several aspects of LDKT require critical attention
to make the process as safe as possible and prevent ‘never
events’ from occurring. These elements include attestation* Correspondence: goldfad@ccf.org
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article, unless otherwise stated.of ABO compatibility, knowledge of infectious transmis-
sion risk, attestation of XM compatibility, and assurance
of appropriate organ anatomy. Lack of knowledge in any
of these domains could lead to serious morbidity that is
otherwise preventable.
Surgical checklists have been used successfully to im-
prove safety. A number of studies attest to the effect-
iveness of checklists in accomplishing this [7–11]. To
date, no prior publication describes the prevention of
‘never events’ in LDKT due to safety checklist imple-
mentation. The aim of this project was to design an
EMR-embedded safety checklist to prevent ‘never events’
in LDKTand evaluate its use.Methods
The checklist was created and embedded in the health
system EMR (EPIC, Verona, Wisconsin). It is a separate
encounter, easily created by the recipient surgeon, and is
viewable by anyone accessing the patient record. The
checklist (Fig. 1) contains 5 information domains: demo-
graphics, ABO, XM, infectious disease status, and donor
organ laterality with anatomic details. Demographic and
basic laboratory data from the recipient is populateddistributed under the terms of the Creative Commons Attribution 4.0
ns.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
give appropriate credit to the original author(s) and the source, provide a
indicate if changes were made. The Creative Commons Public Domain
.org/publicdomain/zero/1.0/) applies to the data made available in this
Fig. 1 Depiction of the Electronic Medical Record checklist template
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checklist, preventing transcription error when consoli-
dating the information. Compatibility information, spe-
cifically, cytotoxicity XM testing, flow XM testing, donor
specific antibody status, and calculated/virtual panel re-
active antibody (VPRA) are entered manually by the re-
cipient surgeon.
Donor information is reviewed directly from source
documentation in the EMR and/or outside records.
Donor information is then manually inserted into the
right column of the checklist by the recipient surgeon,
and includes demographics, ABO, and infectious risk. No
donor information is auto-populated into the checklist.
This ensures the surgeon critically reviews this informa-
tion at the time of data entry, enabling any abnormalities
to be identified and addressed.
At the conclusion of the ABO, XM, and infectious risk
sections there is a surgeon attestation statement, which
confirms compatibility (ABO, XM) and safety (infectious
disease transmission risk) of the transplant. The organ
anatomy section includes kidney laterality, the number
of arteries, veins, and ureters, as well as an attestation
confirming discussion with the donor surgeon. Donor
anatomy is determined from available images.
The responsibility for checklist creation rests with the
recipient surgeon. Checklists are completed prior to
transplantation and as soon as possible once all data is
available. Based upon checklist results, additional or re-
peat testing can be ordered as necessary, or surgery may
be cancelled if indicated. The checklists are reviewed by
the surgical team in the preoperative setting prior to any
anesthetic or surgical intervention. This study evaluates
checklist completion rates and effectiveness over the first
27 months of its use. Local institutional review board
approval (study 13–1538) was obtained.
Results
Recipient checklists from September 2011 deployment
through December 2013 were retrospectively reviewed.
A total of 157 LDKT checklists were obtained. Mean re-
cipient age was 48.4 years with 56.6 % male and 43.5 %
female (Table 1). Average body mass index was 26.6 kg/m2
for the group. Checklist completion rate was 87.9 % across
five transplant surgeons.
All completed checklists contained recipient ABO,
while 5.1 % lacked donor information. However, a totalTable 1 Group demographics and overall completion rate
Measure Mean or Percentage
Recipient Age (Years) 48.4
Recipient Body Mass Index (kg/m2) 26.6
Recipient Sex (Male) 56.6 %
Checklist Completion Rate (Overall) 87.9 %of 98.6 % noted ABO compatibility. Similarly, XM infor-
mation was omitted in 7.2 % of checklists (up to 18.1 %
lacked calculated VPRA data) but overall XM was accept-
able in 93.5 % with one erroneously noting incompatibility
(Table 2).
Infectious risk was completely documented in all but
6.5 % of checklists while 98.5 % were deemed acceptable
(Table 3). Anatomic details were present in all but 3.6 %
of checklists. Only 1 (paired donor organ from another
hospital) form did not confirm donor and recipient sur-
geon discussion.
One transplant was cancelled the day before surgery
per inadequate infectious screening identified by the
checklist. No hepatitis C nucleic acid testing result was
available, so the case was postponed 2 weeks. There
were no “never events” (Table 4). Overall, transplants
surgeons found the checklists easy to use and quick to
complete.
Discussion
Living donor transplantation carries risks beyond those
routinely associated with surgery. Significant morbidity
can be attributed to these events, which include ABO
mismatch, infectious transmission, XM incompatibility,
and inappropriate organ anatomy [1, 5, 6]. However, all
are preventable with accurate pre-procedural knowledge.
Many areas in healthcare and other industries utilize
checklists to reduce rates of errors and catastrophic
events [7–11]. This served as motivation for the devel-
opment of the LDKT checklist.
An EMR-based safety checklist was developed, which
is easy to use and helps prevent LDKT ‘never events’
from occurring. Recipient information from the EMR is
automatically loaded into the checklist. Donor informa-
tion is manually entered into the tool directly from
source documentation, fostering critical review of each
entry by the surgeon. Additionally, the tool requires
safety attestations in multiple domains by the recipient
surgeon. It also enables source documentation informa-
tion to be centralized into a single location that is readily
accessible to all transplant team members .
While the advantages of this checklist have been dis-
cussed, limitations also exist. Manual entry of donor
data directly from source documentation does foster
critical review, however it is subject to human error and
inaccurate data transcription. Likewise, it is possible thatTable 2 Blood type and immunologic information
Checklist Measure N = 157
Missing Blood Type Data 5.1 %
Blood Type Marked Compatible 98.6 %
Missing Cross Match Data 7.2 %
Cross Match Marked Compatible 93.5 %
Table 3 Infectious risk and anatomic details
Checklist Measure N = 157
Missing Infectious Risk Data 6.52 %
Infectious Risk Marked Acceptable 98.5 %
Missing Anatomic Data 3.6 %
Anatomy Discussed with Donor Surgeon 99.4 %
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that may present – another illustration of the human
factor. Either situation could potentially result in adverse
events. Incorporating review of the completed checklist by
another surgeon, versus his or her completion of a separ-
ate checklist for comparison, may reduce the chance of
erroneous checklist data, but again, would not eliminate it
due to human nature.
Documented transmission of donor-derived infectious
disease and/or malignancy highlight the types of inci-
dents such a checklist can prevent [12, 2, 13–19]. A
study of pre-operative checklist use in living donor liver
transplantation produced positive results, however re-
cipient outcomes were not thoroughly investigated [20].
Overall, the LDKT checklist presented here was met
with good utilization by the transplant surgeons and
was deemed easy to use. It provided a final checkpoint
prior to transplantation once all donor and recipient in-
formation was known.
Since LDKT checklist implementation, no “never
events” have occurred. One transplant was deferred
due to missing infectious risk information. This elimi-
nated any harm that may have been conferred to the
organ recipient. It also showed that the surgical team
must remain committed, and if needed, make difficult
decisions based upon checklist results. Consideration
is being given to implementing a similar tool for cadaveric
kidney transplantation, however, in a much more acute
timeframe, the utility and feasibility of completing such a
checklist is unclear.
Incomplete compliance was noted in various checklist
domains. In some instances, compatibility and/or infec-
tious transmission risk were known by the surgeon and
deemed acceptable, but test results to support the attest-
ation were not entered. This lack of completeness is
problematic, as the medical record is a legal document
where lacking documentation can be presumed to signifyTable 4 Outcomes during checklist use
Checklist Measure N = 157
“Never Events” 0.0 %
Surgery Cancellation 0.0 %
Surgery Delay or Rescheduling 0.66 %tests were not completed. Short of 100 % compliance,
effectiveness of the checklist is compromised. Promoting
compliance will require continued surgeon education
and an emphasis on checklist importance.
A recent institutional initiative called for the develop-
ment of care paths to standardize patient management,
ensure quality, and control costs. A renal transplantation
care path was created and requires use of the LDKT
checklist. Furthermore, as part of a quality initiative, a
departmental quality officer now monitors compliance
and notifies surgeons of any deficiencies with checklist
completion to foster improvement. The checklist is up-
dated periodically. It was recently expanded to include
viral nucleic acid testing, West Nile virus testing, and
Strongyloides testing, if indicated, per updated institu-
tional and UNOS guidelines.
Strengths of this study include the review of all pa-
tients scheduled for LDKT, which identifies all cases re-
gardless of whether a checklist was completed or not,
as opposed to querying the EMR for the presence of a
checklist. Another strength is that the study occurred
in a high-volume, multi-surgeon transplant group. This
allows the usage patterns of different individuals to be
averaged together, potentially making the data more
generalizable. Limitations of the study are inherent to
its retrospective nature.Conclusions
An EMR-based safety checklist for LDKT was success-
fully designed and implemented. Retrospective review
of its utilization showed good initial compliance. During
use of the LDKT checklist, no “never events” occurred.
The checklist is easy to use and can be completed quickly.
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